biotech / news / / Sky News
Whitehall officials and ministers will invite bosses from companies including AstraZeneca and GSK to join the new working group in the coming weeks.
A new government-industry panel will devise a future pricing regime for key medicines in the UK.
KEY POINTS
- Executives from AstraZeneca and GSK will be invited to join this panel in the coming weeks.
- The UK-US drug-pricing deal makes the NHS pay 25% more for branded medicines and cuts the clawback tax.
- The panel will consider replacing VPAG with models linking drug pricing to development activity in the UK.
COMPANIES
Summarized by Newsio from Sky News. How we summarize →